| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | €86,9974 | +7,36% | €1,23B | €266,04K | |
TMP Tompkins Financial Corporation | €83,1307 | -3,17% | €1,23B | €64,27K | |
BRUN Boost Run Inc. Class A Common Stock | €16,2973 | -5,46% | €1,23B | €2,90M | |
TWFG TWFG, Inc. Common Stock | €23,5681 | +2,76% | €1,23B | €151,43K | |
PCT PureCycle Technologies, Inc. Common stock | €6,1318 | +4,07% | €1,23B | €3,91M | |
REX REX American Resources Corp. | €37,5703 | -0,57% | €1,23B | €108,79K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | €6,6499 | -7,01% | €1,23B | €72,66K | |
BTT BlackRock Municipal 2030 Target Term Trust | €19,5657 | +1,13% | €1,23B | €35,41K | |
ADNT Adient plc Ordinary Shares | €16,8111 | +0,77% | €1,22B | €595,16K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | €23,1142 | -0,04% | €1,22B | €1,57M | |
| €31,8666 | -0,93% | €1,22B | €981,11K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | €2,4407 | -8,65% | €1,22B | €491,56K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | €14,2762 | -2,00% | €1,22B | €96,87K | |
REPL Replimune Group, Inc. | €12,6833 | -4,94% | €1,22B | €2,92M | |
HCSG Healthcare Services Group | €19,6458 | +4,56% | €1,22B | €911,85K | |
